Mayo, T., Armstrong, A., Kircik, L., Silverberg, J., Blauvelt, A., Esdaile, B., Schneider, S., Mark, T., Gooderham, M., & Alexis, A. (2023). Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. SKIN The Journal of Cutaneous Medicine, 7(2), s144. https://doi.org/10.25251/skin.7.supp.144